Francisco J Cimas Selected Research

Francisco J Cimas Research Topics

14	Neoplasms (Cancer) 01/2022 - 06/2015
9	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 01/2017
1	Obesity 06/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Breakthrough Infections 01/2023
1	COVID-19 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2015
1	Lung Neoplasms (Lung Cancer) 06/2015

5	AntibodiesIBA 04/2021 - 01/2018
2	CytokinesIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2019
2	LigandsIBA 09/2021 - 08/2020
2	Cisplatin (Platino)FDA LinkGeneric 12/2015 - 06/2015
1	LipidsIBA 06/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2023
1	Radiation-Sensitizing AgentsIBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	VaccinesIBA 01/2023
1	Interleukin-15 (Interleukin 15)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	Phenobarbital (Luminal)FDA Link 10/2021
1	AminesIBA 09/2021
1	Ruthenium CompoundsIBA 09/2021
1	CymenesIBA 09/2021
1	RutheniumIBA 09/2021
1	Platinum Compounds (Compounds, Platinum)IBA 09/2021
1	IntegrinsIBA 06/2021
1	Proteolysis Targeting ChimeraIBA 10/2020
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 08/2020
1	RNA (Ribonucleic Acid)IBA 08/2020
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2019
1	ChemokinesIBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017